A new drug developed by Tel Aviv University researchers, BL-7050, is offering new hope to patients with neuropathic pain. In both in-vitro and in-vivo experiments measuring electrical activity of neurons, the compound has been shown to prevent the hyperexcitability of neurons – protecting against neuropathic pain. READ MORE
Source: Science Daily